Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -125,170 | -114,446 | -55,145 | -213,913 | -156,468 |
| Depreciation Amortization | 8,890 | 6,533 | 3,081 | 11,418 | 8,261 |
| Accounts receivable | 19,727 | 10,897 | 466 | -5,380 | -5,431 |
| Other Working Capital | 5,634 | 13,897 | 6,146 | -715 | -1,728 |
| Other Operating Activity | -2,371 | 6,608 | 2,232 | 29,189 | 23,809 |
| Operating Cash Flow | $-93,290 | $-76,511 | $-43,220 | $-179,401 | $-131,557 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 2,965 | -2,034 | N/A | -2,928 | -2,537 |
| Net Acquisitions | N/A | -5,000 | -5,000 | -20,000 | N/A |
| Purchase Sale Intangibles | -5,000 | N/A | N/A | N/A | -20,000 |
| Other Investing Activity | -5,005 | -5 | 0 | 0 | -20,000 |
| Investing Cash Flow | $-2,040 | $-7,039 | $-5,000 | $-22,928 | $-22,537 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 28,000 | 5,000 | N/A |
| Debt Issued | 27,909 | 27,910 | N/A | 47,112 | 47,112 |
| Debt Repayment | -50,375 | -40,375 | N/A | N/A | N/A |
| Common Stock Issued | 13,450 | 38,962 | 13,325 | 6,723 | 447 |
| Common Stock Repurchased | N/A | N/A | N/A | -1,105 | -1,698 |
| Dividend Paid | -6,580 | -4,387 | -2,194 | -8,780 | -6,587 |
| Other Financing Activity | 4,717 | -30,304 | -16,944 | 26,369 | 17,427 |
| Financing Cash Flow | $-10,879 | $-8,194 | $22,187 | $75,319 | $56,701 |
| Beginning Cash Position | 180,954 | 180,954 | 180,954 | 307,964 | 307,964 |
| End Cash Position | 74,745 | 89,210 | 154,921 | 180,954 | 210,571 |
| Net Cash Flow | $-106,209 | $-91,744 | $-26,033 | $-127,010 | $-97,393 |
| Free Cash Flow | |||||
| Operating Cash Flow | -93,290 | -76,511 | -43,220 | -179,401 | -131,557 |
| Capital Expenditure | -3,035 | -2,034 | N/A | -3,055 | -2,664 |
| Free Cash Flow | -96,325 | -78,545 | -43,220 | -182,456 | -134,221 |